Empowerment group therapy for refugees with affective disorders: results of a multicenter randomized controlled trial

• Published in: European psychiatry Vol. 66; no. 1; p. e64
• Main Authors: Wiechers, Maren, Strupf, Michael, Bajbouj, Malek, Böge, Kerem, Karnouk, Carine, Goerigk, Stephan, Kamp-Becker, Inge, Banaschewski, Tobias, Rapp, Michael, Hasan, Alkomiet, Falkai, Peter, Jobst-Heel, Andrea, Habel, Ute, Stamm, Thomas, Heinz, Andreas, Hoell, Andreas, Burger, Max, Bunse, Tilmann, Hoehne, Edgar, Mehran, Nassim, Kaiser, Franziska, Hahn, Eric, Plener, Paul, Übleis, Aline, Padberg, Frank
• Format: Journal Article
• Language: English
• Published: England Cambridge University Press 17.07.2023
• Subjects: affective disorders; depression; Emotional regulation; Emotions; Empowerment; global mental health; Group therapy; Humans; Intervention; Linguistics; Mental depression; Mental disorders; Mental health; Mood Disorders; Persian language; Psychotherapy; Psychotherapy, Group; Quality of Life; Questionnaires; Refugees; Refugees - psychology; Resilience (Psychology); Stress; Stress Disorders, Post-Traumatic - psychology; Syria; Iraq; affective disorders; Refugees; depression; group therapy; global mental health
• ISSN: 0924-9338; 1778-3585; 1778-3585
• DOI: 10.1192/j.eurpsy.2023.2431

Against the background of missing culturally sensitive mental health care services for refugees, we developed a group intervention ) for refugees at level 3 within the stratified Stepped and Collaborative Care Model of the project (MEHIRA). We aim to evaluate the effectiveness of the group intervention with its focus on psychoeducation, stress management, and emotion regulation strategies in a culturally sensitive context for refugees with affective disorders compared to treatment-as-usual (TAU). At level 3 of the MEHIRA project, 149 refugees and asylum seekers with clinically relevant depressive symptoms were randomized to the group intervention or TAU. Treatment comprised 16 therapy sessions conducted over 12 weeks. Effects were measured with the Patient Health Questionnaire-9 (PHQ-9) and the Montgomery-Åsberg Depression Rating Scale (MÅDRS). Further scales included assessed emotional distress, self-efficacy, resilience, and quality of life. Intention-to-treat analyses show significant cross-level interactions on both self-rated depressive symptoms (PHQ-9;  = 13.32,  < 0.001) and clinician-rated depressive symptoms (MÅDRS;  = 6.91,  = 0.01), indicating an improvement in depressive symptoms from baseline to post-intervention in the treatment group compared to the control group. The effect sizes for both scales were moderate (  = 0.68, 95% CI 0.21-1.15 for PHQ-9 and  = 0.51, 95% CI 0.04-0.99 for MÅDRS). In the MEHIRA project comparing an SCCM approach versus TAU, the group intervention at level 3 showed effectiveness for refugees with moderately severe depressive symptoms.